Early experience with a low FODMAP diet in Asian patients with irritable bowel syndrome
- PMID: 30483586
- PMCID: PMC6207042
- DOI: 10.1002/jgh3.12069
Early experience with a low FODMAP diet in Asian patients with irritable bowel syndrome
Abstract
Background: The efficacy and acceptance of a low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet in Asian adults with irritable bowel syndrome (IBS) remain uncertain. We aimed to describe our early experience in a single center with a dedicated gastroenterology dietetic service.
Methods: Consecutive patients with IBS referred to our dedicated Dietetic Gastroenterology Clinic between February 2016 and May 2016 were screened. A low FODMAP diet was instituted as per standard protocol. Data on demographic and clinical variables were obtained from patients' records and prospective telephone interviews.
Results: A total of 16 patients, with a median age of 67 ± 13.57 years; female gender n = 10 (62.5%); ethnicity: Chinese n = 8 (50%), Indian n = 5 (31.25%), and Malay n = 3 (18.75%) with IBS, were included in the study. Compliance with the low FODMAP diet was complete in 8 of 16 (50%) patients, partial in 4 of 16 (25%), and 4 of 16 (25%) could not comply with the diet at all. Improvement in symptoms were reported in 11 of 16 (68.8%) patients. Among patients who complied (complete/partial) with the low FODMAP diet, predominant symptom improvement was reported as follows: abdominal pain 3 of 5 (60%), abdominal bloating/distension 7 of 10 (70%), and flatulence 7 of 8 (87.5%). Patients with the IBS-D subtype appeared to have the greatest improvement in stool consistency (87.5% IBS-D vs 12.5% non-IBS-D, P = 0.009).
Conclusion: Based on our pilot observational study of a relatively small sample of Asian IBS patients, compliance with a low FODMAP diet appears to be low. Further larger studies are required to verify our observation.
Keywords: Asia; early experience; irritable bowel syndrome; low fermentable oligosaccharides, disaccharides, monosaccharides and polyols diet; treatment.
Similar articles
-
The Efficacy of the Low-FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) Diet in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.Cureus. 2025 Jan 7;17(1):e77053. doi: 10.7759/cureus.77053. eCollection 2025 Jan. Cureus. 2025. PMID: 39917138 Free PMC article. Review.
-
A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D.Am J Gastroenterol. 2016 Dec;111(12):1824-1832. doi: 10.1038/ajg.2016.434. Epub 2016 Oct 11. Am J Gastroenterol. 2016. PMID: 27725652 Clinical Trial.
-
Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies.PLoS One. 2017 Aug 14;12(8):e0182942. doi: 10.1371/journal.pone.0182942. eCollection 2017. PLoS One. 2017. PMID: 28806407 Free PMC article.
-
A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.Gastroenterology. 2014 Jan;146(1):67-75.e5. doi: 10.1053/j.gastro.2013.09.046. Epub 2013 Sep 25. Gastroenterology. 2014. PMID: 24076059 Clinical Trial.
-
[Low Fermentable Oligo-, Di- and Monosaccharides and Polyols (FODMAP) diet in the treatment of patients with irritable bowel syndrome: basic principles and methodology].Vopr Pitan. 2020;89(6):38-47. doi: 10.24411/0042-8833-2020-10077. Epub 2020 Nov 20. Vopr Pitan. 2020. PMID: 33476497 Review. Russian.
Cited by
-
Global Dietary Patterns and Functional Gastrointestinal Disorders.Children (Basel). 2020 Sep 27;7(10):152. doi: 10.3390/children7100152. Children (Basel). 2020. PMID: 32992448 Free PMC article. Review.
-
Experiences of ethnic minority patients who are living with a primary chronic bowel condition: a systematic scoping review with narrative synthesis.BMC Gastroenterol. 2021 Aug 18;21(1):322. doi: 10.1186/s12876-021-01857-8. BMC Gastroenterol. 2021. PMID: 34407752 Free PMC article.
-
All that a physician should know about FODMAPs.Indian J Gastroenterol. 2019 Oct;38(5):378-390. doi: 10.1007/s12664-019-01002-0. Epub 2019 Dec 4. Indian J Gastroenterol. 2019. PMID: 31802437 Review.
-
The Efficacy of the Low-FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) Diet in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.Cureus. 2025 Jan 7;17(1):e77053. doi: 10.7759/cureus.77053. eCollection 2025 Jan. Cureus. 2025. PMID: 39917138 Free PMC article. Review.
-
A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for depression in irritable bowel syndrome.Sci Rep. 2024 Apr 25;14(1):9478. doi: 10.1038/s41598-024-60029-2. Sci Rep. 2024. PMID: 38658619 Free PMC article. Clinical Trial.
References
-
- Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006; 130: 1480–91. - PubMed
-
- Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta‐analysis. Clin. Gastroenterol. Hepatol. 2012; 7: 712–21.e4. - PubMed
-
- Tan YM, Goh KL, Muhidayah R, Ooi CL, Salem O. Prevalence of irritable bowel syndrome in young adult Malaysians: a survey among medical students. J. Gastroenterol. Hepatol. 2003; 18: 1412–6. - PubMed
-
- Rajendra S, Alahuddin S. Prevalence of irritable bowel syndrome in a multi‐ethnic Asian population. Aliment. Pharmacol. Ther. 2004; 19: 704–6. - PubMed
LinkOut - more resources
Full Text Sources